Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
John C. Atherton, Martin J. Blaser
John C. Atherton, Martin J. Blaser
View: Text | PDF
Review Series

Coadaptation of Helicobacter pylori and humans: ancient history, modern implications

  • Text
  • PDF
Abstract

Humans have been colonized by Helicobacter pylori for at least 50,000 years and probably throughout their evolution. H. pylori has adapted to humans, colonizing children and persisting throughout life. Most strains possess factors that subtly modulate the host environment, increasing the risk of peptic ulceration, gastric adenocarcinoma, and possibly other diseases. H. pylori genes encoding these and other factors rapidly evolve through mutation and recombination, changing the bacteria-host interaction. Although immune and physiologic responses to H. pylori also contribute to pathogenesis, humans have evolved in concert with the bacterium, and its recent absence throughout the life of many individuals has led to new human physiological changes. These may have contributed to recent increases in esophageal adenocarcinoma and, more speculatively, other modern diseases.

Authors

John C. Atherton, Martin J. Blaser

×

Figure 6

Overviews of H. pylori relationships to health and disease.

Options: View larger image (or click on image) Download as PowerPoint
Overviews of H. pylori relationships to health and disease.
   
(A) Anci...
(A) Ancient, premodern, and postmodern stomachs. From ancient times, normal human physiology in the presence of H. pylori pan-gastritis has avoided disease until the gastric cancers of old age. We speculate that premodern changes in the pattern of colonization and inflammation in the stomach resulted in changes in physiology and the rise of peptic ulcer disease (PUD). In the postmodern (current) era, the absence of H. pylori leads to distorted physiology, to which we have not fully adapted. This may have led to disease in some children and adults but avoids gastric cancer in old age. (B) A model of the proposed biphasic nature of H. pylori and human disease. Because we have coevolved with H. pylori, the changed physiology resulting from an H. pylori–free stomach may contribute to some modern diseases. Thus, from a postmodern viewpoint, H. pylori may confer benefits to humans early in their life span. Possible examples include reducing infectious diseases, controlling allergy, regulating gastric hormones such as leptin and ghrelin (benefits uncertain), and reducing gastroesophageal reflux disease sequelae. Later in life, H. pylori has biological costs, inducing ulcers, (possible) metabolic disturbances, anemia, and gastric cancers, all more prominent in an ageing population. In both A and B, black text indicates information for which there is strong evidence — for these, the balance is toward a net deleterious effect of H. pylori on human health — and red text indicates information for which evidence remains under debate. cag-negative strains are less interactive with humans, conferring smaller risks and putative benefits.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts